Regulatory Sourcebook eBook
Read the article:
Changing the Course of Drug Shortages
Read the eBook:
Pharmaceutical Technology's Regulatory Sourcebook eBook
CONTINUE TO SITE
OR WAIT null SECS
Advertisement
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Changing the Course of Drug Shortages
Published on:
Meg Rivers
Pharmaceutical Technology, Pharmaceutical Technology, Regulatory Sourcebook, September 2021, Volume 2021 eBook, Issue 3
Pages: 16-22
The COVID-19 pandemic has further impacted ongoing drug shortage issues; essential action is needed to avoid repeating previous mistakes.
Drug shortages were a major concern before the COVID-19 pandemic, which only served to further add pressure to an imperfect supply chain. The COVID-19 pandemic placed added pressure on bio/pharma’s imperfect supply chain, contributing to ongoing drug shortages and creating some new challenges. What has the industry learned from the pandemic and will practices and supply-related decisions change going forward?
Regulatory Sourcebook
Read this article in Pharmaceutical Technology's September 2021 Regulatory Sourcebook.
Advertisement
About the author
Meg Rivers is a senior editor at Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.
Article Details
Pharmaceutical Technology
eBook: Regulatory Sourcebook, September 2021
September 2021
Pages: 16-22
Citation
When referring to this article, please cite it as M. Rivers, “Changing the Course of Drug Shortages," Pharmaceutical Technology Regulatory Sourcebook eBook (September 2021).
